Supply, Storage and Release of Vaccines against Lumpy Skin Disease

Summary

The tender concerns the supply, storage and release of vaccines against Lumpy skin disease (LSD) in the Netherlands. The supplier must provide a live attenuated homologous vaccine based on the Neethling strain, maintain an initial stock of 500,000 doses at a GDP-certified storage site in the Netherlands, and make doses available within 24 hours of an emergency call. The contract is for one year with three one-year extension options and is intended for one supplier. The estimated value for the full four-year term is EUR 4,850,000 excluding VAT; the maximum contract value is EUR 5,820,000 excluding VAT. The tender deadline is 8 October 2026 at 10:00. Price is the only award criterion, and bids must be submitted electronically. No tender guarantee is required.